For the Quarter Ending March 2026
Albuterol Sulphate Prices in North America
- In United States, the Albuterol Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Albuterol Sulphate Production Cost Trend increased in March 2026 as PPI rose 4.0% and CPI hit 3.3%.
- The Manufacturing Index expanded and industrial production grew 0.7% in March 2026, supporting stable operations.
- The Albuterol Sulphate Demand Outlook strengthened in March 2026, supported by 4.0% retail sales and 4.3% unemployment.
- Consumer confidence reached 91.8 in March 2026, sustaining routine healthcare engagement and consistent prescription fulfillment.
- Upstream petrochemical feedstock costs for Albuterol Sulphate synthesis surged in March 2026 alongside crude oil.
- Domestic supply of inhalation aerosol expanded following new generic manufacturing capacity approvals in March 2026.
- United States exports of salicylic acid salts, a key precursor, plummeted sharply in January 2026.
- The Albuterol Sulphate Price Forecast showed upward pressure in March 2026 as the Albuterol Sulphate Price Index climbed.
Why did the price of Albuterol Sulphate change in March 2026 in North America?
- Upstream petrochemical feedstock costs surged in March 2026 due to escalating Brent crude oil prices.
- Demand for inhalation products strengthened significantly during the peak respiratory virus season in March 2026.
- A major regional producer halted operations, tightening the supply of nebulizer solutions in January 2026.
Albuterol Sulphate Prices in APAC
- In China, the Albuterol Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Producer Price Index rose 0.5% in March 2026, reflecting an increased Albuterol Sulphate Production Cost Trend.
- A Consumer Price Index increase of 1.0% in March 2026 supported a stable Albuterol Sulphate Demand Outlook.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, ensuring Albuterol Sulphate supply volumes.
- Retail sales grew 1.7% in March 2026, reflecting softer consumer spending on Albuterol Sulphate respiratory medications.
- The unemployment rate reached 5.4% in March 2026, straining household incomes for premium Albuterol Sulphate healthcare spending.
- Consumer confidence dropped to 91.6 in February 2026, driving patients toward more affordable generic Albuterol Sulphate alternatives.
- Naphtha and propylene feedstock costs for Albuterol Sulphate precursors surged in March 2026 amid geopolitical disruptions.
- The Albuterol Sulphate Price Forecast remained elevated in March 2026 as freight costs for chemical intermediates spiked.
Why did the price of Albuterol Sulphate change in March 2026 in APAC?
- Naphtha and propylene feedstock costs surged in March 2026 due to Middle East supply disruptions.
- Freight costs for imported chemical intermediates spiked in March 2026 amid Strait of Hormuz disruptions.
- Domestic supply of propylene-derived precursors tightened in March 2026 following aggressive producer withholding of stock.
Albuterol Sulphate Prices in Europe
- In Germany, the Albuterol Sulphate Price Index remained stable quarter-over-quarter in Q1 2026, balancing weak demand and tight supply.
- The Albuterol Sulphate Production Cost Trend fluctuated as salicylic acid feedstock costs declined steadily through March 2026.
- The Albuterol Sulphate Demand Outlook weakened as German pharmaceutical manufacturing output contracted significantly in February 2026.
- The Albuterol Sulphate Price Forecast stabilized in Q1 2026 as regional inventories of inhalation products remained tight.
- Higher inflation at 2.7% and declining producer prices at -0.2% in March 2026 created mixed Albuterol Sulphate cost pressures.
- The Manufacturing Index expanded in March 2026, tightening the supply of basic chemical precursors for Albuterol Sulphate.
- Stagnant industrial production at 0.0% in February 2026 reflected flat baseline availability of Albuterol Sulphate reagents.
- Retail sales growth of 0.7% and a 4.2% unemployment rate in February 2026 sustained Albuterol Sulphate demand.
- Negative consumer confidence at -24.7 in March 2026 indicated cautious spending, slightly impacting preventative Albuterol Sulphate treatments.
Why did the price of Albuterol Sulphate change in March 2026 in Europe?
- German natural gas exchange prices surged in March 2026, increasing Albuterol Sulphate energy production costs.
- Salicylic acid feedstock costs declined across Europe in Q1 2026, easing Albuterol Sulphate manufacturing overheads.
- Pharmaceutical wholesale inventories remained constrained in Q1 2026, supporting Albuterol Sulphate prices despite weakened demand.
For the Quarter Ending December 2025
Albuterol Sulphate Prices in North America
- In United States, the Albuterol Sulphate Price Index rose quarter-over-quarter in Q4 2025, influenced by rising production costs.
- Albuterol Sulphate production costs increased from a 3.0% year-over-year PPI rise in November 2025.
- Higher labor costs from a 4.4% unemployment rate in December 2025 impacted Albuterol Sulphate production expenses.
- Demand for Albuterol Sulphate strengthened in December 2025 due to increased influenza and RSV activity.
- The Albuterol Sulphate Price Forecast indicates upward pressure from strengthening US natural gas spot prices in late 2025.
- US manufacturing inventories contracted in October 2025, tightening Albuterol Sulphate supply chain availability.
- Industrial production increased 2.0% year-over-year in December 2025, supporting stable supply chains for precursors.
- Consumer Price Index rose 2.7% year-over-year in December 2025, raising operational costs for manufacturers.
- Strong retail sales (3.3% YoY Nov 2025) and moderate consumer confidence (89.1 Dec 2025) supported healthcare demand.
Why did the price of Albuterol Sulphate change in December 2025 in North America?
- Production costs rose from a 3.0% year-over-year PPI increase in November 2025.
- Demand increased in December 2025 due to elevated influenza and RSV activity.
- Strengthening natural gas spot prices in late 2025 raised energy and feedstock costs.
Albuterol Sulphate Prices in APAC
- In China, the Albuterol Sulphate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Albuterol Sulphate production costs declined in December 2025, as producer prices fell by 1.9% year-over-year.
- Overall chemical market demand in China weakened in 2025, despite pharmaceutical sector growth driven by demographics.
- The Manufacturing Index expanded in December 2025, indicating a growing industrial environment for chemical production.
- Industrial production in China increased by 5.2% year-over-year in December 2025, supporting chemical supply chains.
- Weak consumer spending, with retail sales growing only 0.9% year-over-year in December 2025, indirectly impacted healthcare demand.
- Chemical manufacturers maintained reduced inventory levels in 2025 due to persistent oversupply and earlier weakening demand.
- China's medicine exports experienced steady growth during the first eleven months of 2025, supporting trade flows.
- The Albuterol Sulphate Price Forecast suggests continued pressure from global overcapacity in Q4 2025.
Why did the price of Albuterol Sulphate change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, reducing Albuterol Sulphate manufacturing costs.
- The chemical industry faced significant oversupply in 2025, pressuring Albuterol Sulphate producer margins.
- Weak consumer demand, with CPI at 0.8% in December 2025, indirectly impacted overall healthcare spending.
Albuterol Sulphate Prices in Europe
- In Germany, the Albuterol Sulphate Price Index fell in Q4 2025, influenced by declining producer prices and slowing sector demand.
- Albuterol Sulphate production costs declined in December 2025, as producer prices of industrial products fell 2.5% year-over-year.
- The Manufacturing Index showed a Contracting trend in December 2025, indicating a slowdown in overall economic activity.
- Demand for Albuterol Sulphate was impacted by slowing European chemical sector demand during Q4 2025.
- German industrial production grew 0.8% year-over-year in October 2025, supporting stable supply chain inputs.
- Elevated European natural gas prices and increased electricity charges in 2025 pressured Albuterol Sulphate production costs.
- The Consumer Price Index rose 1.8% in December 2025, while retail sales grew 1.1% in November 2025.
- Unemployment at 6.2% and negative consumer confidence (-17.5 index) in December 2025 affected patient affordability and demand.
Why did the price of Albuterol Sulphate change in December 2025 in Europe?
- Producer prices of industrial products declined 2.5% year-over-year in December 2025, reducing input costs.
- European chemical sector demand was slowing in Q4 2025, impacting overall market sentiment.
- Elevated energy costs in 2025, including natural gas and electricity, maintained upward pressure on production.
For the Quarter Ending September 2025
Albuterol Sulphate Prices in APAC
- In China, the Albuterol Sulphate Price Index fell quarter-over-quarter in Q3 2025, driven by deflationary pressures.
- Albuterol Sulphate production costs decreased in September 2025, as the Producer Price Index fell 2.3% year-over-year.
- Petrochemical feedstock prices remained steady in Q3 2025, while Brent crude oil spot prices weakened.
- The Albuterol Sulphate demand outlook is bearish, influenced by a 0.3% CPI decline in September 2025.
- Consumer confidence at 89.6 and a 5.2% unemployment rate in September 2025 suggest reduced healthcare spending.
- China's general chemical demand slowed in 2025, impacting Albuterol Sulphate consumption and market sentiment.
- Industrial production increased 6.5% year-over-year in September 2025, ensuring stable raw material supply for production.
- Global overcapacity in the chemicals sector, particularly from China, persisted throughout Q3 2025, pressuring prices.
Why did the price of Albuterol Sulphate change in September 2025 in APAC?
- Deflationary pressures, with CPI falling 0.3% in September 2025, reduced overall market demand.
- Producer Price Index decreased 2.3% year-over-year in September 2025, lowering Albuterol Sulphate production costs.
- Contracting manufacturing activity in September 2025, alongside global overcapacity, pressured Albuterol Sulphate prices downwards.
Albuterol Sulphate Prices in Europe
- In Germany, the Albuterol Sulphate Price Index remained stable in Q3 2025, due to cautious demand and mixed cost pressures.
- Albuterol Sulphate production costs faced upward pressure from a 2.4% CPI increase in September 2025, impacting non-chemical inputs.
- Albuterol Sulphate manufacturing costs benefited from a 1.7% decrease in producer prices in September 2025, driven by lower energy costs.
- The Manufacturing Index was contracting in Q3 2025, indicating broader industrial slowdown and potential supply chain challenges.
- Albuterol Sulphate demand outlook remained cautious in Q3 2025, with customers exhibiting weak sentiment across chemical end markets.
- Industrial production declined 1.0% in September 2025, suggesting operational challenges affecting Albuterol Sulphate manufacturing.
- Germany's unemployment rate remained stable at 6.3% in September 2025, impacting healthcare affordability and Albuterol Sulphate access.
- Natural gas border prices in Germany fluctuated in Q3 2025, initially weakening then strengthening in September, affecting energy costs.
Why did the price of Albuterol Sulphate change in September 2025 in Europe?
- Albuterol Sulphate production costs increased due to 2.4% CPI rise in September 2025.
- Lower energy prices, a 1.7% PPI decrease in September 2025, reduced Albuterol Sulphate costs.
- Weak customer demand and contracting Manufacturing Index in Q3 2025 impacted Albuterol Sulphate prices.
Albuterol Sulphate Prices in North America
- In the United States, the Albuterol Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and robust demand.
- Albuterol Sulphate production costs increased due to a 2.6 percent rise in the Producer Price Index in August 2025 and higher natural gas prices.
- Demand for Albuterol Sulphate was supported by a 5.42 percent year-over-year increase in retail sales in September 2025, indicating strong consumer spending.
- The Albuterol Sulphate demand outlook is positive, bolstered by a low unemployment rate of 4.3 percent in September 2025, enhancing healthcare access.
- Chemical industry customer inventories for Albuterol Sulphate were assessed as low in Q3 2025, contributing to upward price pressure.
- Trade flows for imported goods into the U.S. faced tariff impacts and border delays in Q3 2025, affecting Albuterol Sulphate supply chains.
- The Albuterol Sulphate Price Forecast suggests continued upward pressure due to persistent input cost increases and strengthening pharmaceutical sector activity.
- Overall industrial production in September 2025 was only 0.1 percent above its year-earlier level, suggesting broader economic headwinds.
- Consumer confidence declined to 94.2 in September 2025, potentially leading to increased price sensitivity for essential medications like Albuterol Sulphate.
Why did the price of Albuterol Sulphate change in September 2025 in North America?
- Rising input costs, evidenced by a 2.6 percent PPI increase in August 2025, directly elevated Albuterol Sulphate production expenses.
- Strong consumer spending, with retail sales up 5.42 percent in September 2025, supported consistent demand for essential pharmaceuticals.
- Low customer inventories in Q3 2025, coupled with higher U.S. natural gas prices, contributed to the upward price trend.
